MedTrace Logo

Early Evaluation of the MAMAACT Trial

NCT04261400 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2020-02-07

No results posted yet for this study

Summary

The MAMAACT#1 project's aim was to reduce ethnic disparity in stillbirth and infant death by improving the management of pregnancy complications through timely and appropriate response to warning signs of pregnancy. The intervention consisted of a training program for midwives and health education materials for pregnant women. The aim of the feasibility trial was to analyze the acceptability and feasibility of the MAMAACT intervention using mini-group interviews with midwives and to pilot outcome evaluation using surveys.

Conditions

  • Pregnancy Complications

Interventions

BEHAVIORAL

MAMAACT

Improved communication regarding warning signs of pregnancy complications

Sponsors & Collaborators

  • Hvidovre University Hospital

    collaborator OTHER

  • The Danish Council for Strategic Research

    collaborator OTHER

  • University of Copenhagen

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2015-06-01
Completion
2015-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04261400 on ClinicalTrials.gov